Obesity News and Research

Latest Obesity News and Research

What RFK Jr. might face in his nomination hearings this week

President Donald Trump has nominated Robert F. Kennedy Jr., an environmental lawyer with no formal medical or public health expertise, as secretary of Health and Human Sciences.

28 Jan 2025

Study links changes in opioid neurotransmitters to anorexia nervosa

A study conducted at Turku PET Centre in Finland showed that changes in the functioning of opioid neurotransmitters in the brain may underlie anorexia.

27 Jan 2025

Global cannabis boom brings unexpected cardiovascular risks to light

This review examines the cardiovascular risks associated with cannabis, revealing its potential to cause severe heart health issues and inform public policy.

27 Jan 2025

Bariatric surgery reduces liver complications in obese patients with cirrhosis

A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious liver complications compared with patients who received medical therapy alone.

27 Jan 2025

Alarming cardiovascular disease statistics highlighted in 2025 report

Heart disease kills more people than any other cause as many of the risks factors that contribute to it remain on the rise, according the data reported in the 2025 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association.

27 Jan 2025

Key immune cells required for tissue repair following liver injury

Our livers contain many different types of immune cells. New research by the team of Prof. Charlotte Scott (VIB-UGent Center for Inflammation Research) and colleagues now reveals that a specific activation state of one of these cell types is required for tissue repair following injury.

24 Jan 2025

Dapagliflozin plus calorie restriction boosts remission rates in adults with type 2 diabetes and obesity

Findings indicate that dapagliflozin and calorie restriction together improve weight loss and metabolic health, increasing the likelihood of diabetes remission.

24 Jan 2025

Study reveals new mechanism behind gene expression regulation in animal cells

A research team at KAIST has identified the core gene expression networks regulated by key proteins that fundamentally drive phenomena such as cancer development, metastasis, tissue differentiation from stem cells, and neural activation processes.

24 Jan 2025

Healthy habits take longer to form than expected

We're nearly one month into 2025, but if you're struggling to hold onto your New Year's resolution, stay strong, as University of South Australia research shows that forming a healthy habit can take longer than you expect.

24 Jan 2025

Study finds successful treatment of childhood obesity lowers long-term health risks

Effective treatment of childhood obesity significantly lowers long-term health risks, including type 2 diabetes and hypertension, promoting better adult health.

24 Jan 2025

Study shows how physical activity can enhance brain function and prevent dementia

A study led by scientists at Rutgers University-New Brunswick has shown that specialized cells involved in how the body responds to insulin are activated in the brain after exercise, suggesting that physical activity may directly improve brain function.

23 Jan 2025

Two-thirds of people with post-COVID-19 syndrome experience long-term effects

Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise capacity and reduced cognitive test performances – for a year or more, with no major changes in symptom clusters during the second year of their illness, according to a new study published January 23rd in the open-access journal PLOS Medicine by Winfried Kern of Freiburg University, Germany, and colleagues.

23 Jan 2025

Non-industrialized diet improves health and reduces disease risk

Researchers have found that a newly developed diet inspired by the eating habits of non-industrialised societies can significantly reduce the risk of a number of chronic diseases – and are to share recipes with the public.

23 Jan 2025

What causes behavioral side effects in popular weight loss drugs?

The study of GLP1R variants shows associations with cardiometabolic traits and behavioral changes, highlighting indirect effects of GLP1RA on mental health.

23 Jan 2025

Trump’s early health moves signal intent to erase Biden’s legacy. What’s next is unclear.

President Donald Trump's early actions on health care signal his likely intention to wipe away some Biden-era programs to lower drug costs and expand coverage under public insurance programs.

23 Jan 2025

Dapagliflozin and calorie restriction show higher remission rates in type 2 diabetes

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher rates of remission compared with calorie restriction alone, finds a trial published by The BMJ today.

23 Jan 2025

Maternal vitamin D deficiency may accelerate fetal aging and impact newborn health

Maternal vitamin D deficiency during pregnancy is linked to accelerated epigenetic gestational age in infants at birth, suggesting improper fetal development influenced by low vitamin D levels. The study also found associations between maternal age, birth height, and epigenetic aging, though cord blood vitamin D showed no significant impact.

22 Jan 2025

Strong heart, strong bones: How cardiovascular health influences bone density

Higher cardiovascular health (Life’s Essential 8 scores) is linked to greater bone mineral density in adults aged 20–59, with stronger associations in younger individuals, women, and those with normal BMI, suggesting heart-healthy habits may protect bone strength.

22 Jan 2025

Why do people with obesity, but without diabetes, start taking semaglutide?

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing significant insurance coverage disparities.

22 Jan 2025

GLP1RA medications linked to behavioral side effects in type 2 diabetes and obesity

Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents-have been linked with behavioral side effects.

22 Jan 2025

Previous
1
...
59
60
61
62
63
64
65
...
1084
Next

Obesity News and Research

Latest Obesity News and Research

What RFK Jr. might face in his nomination hearings this week

Study links changes in opioid neurotransmitters to anorexia nervosa

Global cannabis boom brings unexpected cardiovascular risks to light

Bariatric surgery reduces liver complications in obese patients with cirrhosis

Alarming cardiovascular disease statistics highlighted in 2025 report

Key immune cells required for tissue repair following liver injury

Dapagliflozin plus calorie restriction boosts remission rates in adults with type 2 diabetes and obesity

Study reveals new mechanism behind gene expression regulation in animal cells

Healthy habits take longer to form than expected

Study finds successful treatment of childhood obesity lowers long-term health risks

Study shows how physical activity can enhance brain function and prevent dementia

Two-thirds of people with post-COVID-19 syndrome experience long-term effects

Non-industrialized diet improves health and reduces disease risk

What causes behavioral side effects in popular weight loss drugs?

Trump’s early health moves signal intent to erase Biden’s legacy. What’s next is unclear.

Dapagliflozin and calorie restriction show higher remission rates in type 2 diabetes

Maternal vitamin D deficiency may accelerate fetal aging and impact newborn health

Strong heart, strong bones: How cardiovascular health influences bone density

Why do people with obesity, but without diabetes, start taking semaglutide?

GLP1RA medications linked to behavioral side effects in type 2 diabetes and obesity

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Obesity News and Research

Latest Obesity News and Research

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in